Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity

DK Lee, SR George, BF O'Dowd - Trends in pharmacological sciences, 2006 - cell.com
The apelin receptor was initially classed as an orphan G-protein-coupled receptor, and little
was known about its physiological functions until apelin, the endogenous ligand, was …

[HTML][HTML] Targeting the apelin pathway as a novel therapeutic approach for cardiovascular diseases

JC Zhong, ZZ Zhang, W Wang, SMK McKinnie… - … et Biophysica Acta (BBA …, 2017 - Elsevier
The apelin/apelin receptor system is widely distributed and has a dominant role in
cardiovascular homeostasis and disease. The apelin gene is X-linked and is synthesized as …

The therapeutic potentials of apelin in obesity-associated diseases

I Castan-Laurell, C Dray, P Valet - Molecular and Cellular Endocrinology, 2021 - Elsevier
Apelin, a peptide with several active isoforms ranging from 36 to 12 amino acids and its
receptor APJ, a G-protein-coupled receptor, are widely distributed. However, apelin has …

Translational promise of the apelin–APJ system

G Barnes, AG Japp, DE Newby - Heart, 2010 - heart.bmj.com
Apelin, the endogenous ligand for the G-protein-coupled APJ receptor, is emerging as a key
hormone in cardiovascular homoeostasis. It is expressed in a diverse range of tissues with …

The role of apelin in cardiovascular function and heart failure

B Chandrasekaran, O Dar… - European journal of heart …, 2008 - Wiley Online Library
Apelin is a novel peptide that acts through the APJ receptor, sharing similarities with the
angiotensin II–angiotensin II type 1 receptor pathway. It is a peripheral vasodilator, powerful …

International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function

SL Pitkin, JJ Maguire, TI Bonner, AP Davenport - Pharmacological reviews, 2010 - ASPET
A gene encoding a novel class a G-protein-coupled receptor was discovered in 1993 by
homology cloning and was called APJ. It was designated an “orphan” receptor until 1998 …

The emerging role of apelin in cardiovascular disease and health

R Quazi, C Palaniswamy, WH Frishman - Cardiology in review, 2009 - journals.lww.com
This article focuses on a newly discovered bioactive peptide, termed apelin, as it relates to
the cardiovascular system. Apelin, through its G-protein coupled receptor, seems to primarily …

Apelin and its receptor APJ in cardiovascular diseases

XH Yu, ZB Tang, LJ Liu, H Qian, SL Tang, DW Zhang… - Clinica Chimica …, 2014 - Elsevier
Apelin is an adipokine that has been identified as an endogenous ligand for the orphan
receptor APJ. Apelin and APJ are expressed in a diverse range of tissues with particular …

[HTML][HTML] The role of apelin in cardiovascular diseases, obesity and cancer

MB Wysocka, K Pietraszek-Gremplewicz… - Frontiers in …, 2018 - frontiersin.org
Apelin is an endogenous peptide identified as a ligand of the G protein-coupled receptor
APJ. Apelin belongs to the family of adipokines, which are bioactive mediators released by …

The apelinergic system: a promising therapeutic target

I Falcão-Pires, R Ladeiras-Lopes… - Expert opinion on …, 2010 - Taylor & Francis
Importance of the field: Apelin is a bioactive peptide known as the ligand of the G-protein-
coupled receptor APJ. In recent years, there has been a growing body of evidence regarding …